drugset / Trial / NCT05377203

Low-dose Quadruple Combination Therapy in Patients With Hypertension

NCT05377203

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study aims to compare the antihypertensive effect of initial treatment with a single capsule containing quadruple combination of half-dose of blood pressure medicines or standard dose dual combination in patients with hypertension.

Timeline

Start
2022-07-13
Primary completion
2023-07-04
Completion
2023-07-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 2.5 mg Oral
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Indapamide Small molecule 1.25 mg Oral
Subject Irbesartan Small molecule 75 mg Oral
Subject Irbesartan Small molecule 150 mg Oral
Subject Metoprolol Other / unclassified 23.75 mg Oral

Indications